Person:
VELİOĞLU ÖĞÜNÇ, AYLİZ

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

VELİOĞLU ÖĞÜNÇ

First Name

AYLİZ

Name

Filters

2003 - 200922010 - 20131
Reset filters

Settings

Author: VELİOĞLU ÖĞÜNÇ, AYLİZ × Subject: hypertension ×

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    PublicationOpen Access
    Effects of ACE inhibition and Angiotensin II receptor blockade on glomerular basement membrane protein excretion and charge selectivity in Type 2 diabetic patients
    (J R A A S LTD, 2006-06) VELİOĞLU ÖĞÜNÇ, AYLİZ; Deyneli, Oguzhan; Yavuz, Dilek; Velioglu, Ayliz; Cacina, Hasan; Aksoy, Nihal; Haklar, Goncaguel; Taga, Yavuz; Akalin, Sema
    Angiotensin-converting enzyme (ACE) inhibitors may reduce urinary albumin excretion (UAE) by decreasing glomerular pressure and increasing glomerular charge selectivity through preservation of glycosaminoglycans. The effect of Angiotensin II antagonism on glomerular charge selectivity remains to be determined. The aim of this study was to compare the effects of an AT, blocker losartan and an ACE inhibitor (ACE-I) enalapril on UAE, extracellular matrix proteins, glycosaminoglycan excretion(U-GAG) and red blood cell anionic charge (RBCCh) which are the indirect markers of glomerular basement membrane anionic content in hypertensive Type 2 diabetic patients. Twenty-four patients were randomised into two groups and received either enalapril (5-20 mg/d) or losartan (50-100 mg/d). All parameters were measured at baseline and after six months of treatment. At the end of six months, systolic and diastolic blood pressures (BP), UAE rates, U-GAG excretion and RBCCh were significantly and equally reduced in both treatment groups compared with baseline. RBCCh was negatively correlated with UAE (r = -0.57, p < 0.0001) and U-GAG excretion (r = -0.57, p < 0.0001); UAE was correlated with U-GAG excretion (r = 0.58, p < 0.0001). In conclusion, enalapril and losartan treatment were equally effective in reducing BP, UAE as well as U-GAG excretion and preserving RBCCh in hypertensive Type 2 diabetic patients. ACE inhibition and AT(1)-receptor blockade may have favourable effects on preserving glomerular anionic content in hypertensive diabetic patients.
  • Thumbnail Image
    PublicationOpen Access
    Matrix Metalloproteinase-9 Level and Gene Polymorphism in Sleep Disordered Breathing Patients with or without Cardiovascular Disorders
    (AVES YAYINCILIK, 2013-03-05) VELİOĞLU ÖĞÜNÇ, AYLİZ; Yuksel, Meral; Kuzu-Okur, Hacer; Velioglu-Ogunc, Ayliz; Pelin, Zerrin
    Objective: Obstructive sleep apnea syndrome (OSAS) is associated with increased cardiovascular morbidity and mortality. We aimed to investigate the matrix metalloproteinase-9 (MMP-9) level and MMP-9 gene polymorphism in sleep apnea patients with or without cardiovascular disease. Study Design: Case-control study. Material and Methods: Two hundred nine patients [Mean age (+/- SD), 47 (+/- 12) yrs; M/F, 170/39] diagnosed with sleep-disordered breathing were included in the study. Serum MMP-9 level was performed using enzyme-linked immunosorbant assay (ELISA) and MMP-9 gene polymorphism with polymerase chain reaction-restriction fragment length polymorphism. We divided the patient group into two subgroups: (1) patients with confirmed cardiovascular disease, i.e. CV-P Group and (2) patients without cardiovascular disease, CV-N Group. We compared all parameters between the two groups. Results: There were 56 OSAS patients with cardiovascular disorder (CV-positive group) and 153 OSAS patients without cardiovascular disorder (CV-negative group). CC, CT and TT genotype distributions between groups were similar [31 (55%), 25 (45%), 0 (0%) vs 88 (57%), 61 (40%), 4 (3%); respectively, p>0.05]. MMP-9 level was significantly higher in CV-P patients (442.7 +/- 139.3 pg/mL) than in CV-N patients (364.4 +/- 165.0 pg/mL; p=0.0018). Conclusion: Our results showed that the presence of MMP-9 polymorphism was not associated with cardiovascular disease. MMP-9 level was higher in OSAS patients with cardiovascular disorders than without cardiovascular disorders. Finally, MMP-9 genotype was not associated with serum MMP-9 levels.
  • Thumbnail Image
    PublicationOpen Access
    Effects of ACE inhibition and AT(1)-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients
    (SAGE PUBLICATIONS LTD, 2003-09) VELİOĞLU ÖĞÜNÇ, AYLİZ; Yavuz, D; Koc, M; Toprak, A; Akpinar, I; Velioglu, A; Deyneli, O; Haklar, G; Akalin, S
    Objective Disturbed endothelial function is closely associated with hyperinsulinaemia and insulin resistance in essential hypertension. The alms of this study were: 1) to evaluate whether the two alternative drugs, angiotensin-converting enzyme (ACE) inhibitors and Angiotensin 11 (Ang 11) antagonists, had comparable effects on glucose metabolism and endothelial function. 2) to determine whether they improve endothelial dysfunction through modulating insulin resistance and oxidative stress. Study design and methods Essential hypertensive patients were randomised into two groups: Twelve (nine patients in final analysis) patients were given enalapril (enalapril group), and twelve (nine patients in final analysis) were given losartan (losartan group). Twelve sex- and age-matched normotensive volunteers were included as controls. Before and after six months of treatment, endothelial function, insulin sensitivity and lipid peroxidation (TBARs) and NO metabolites (NOx) were evaluated. Results Endothelial function, measured as flow mediated dilatation (FMD), was improved in both of the treatment groups (p=0.0001). Calculated insulin sensitivity index also improved in the enalapril-treated group (p=0.05) but not in the losartan-treated group, compared with baseline levels. TBARS values decreased significantly in the enalapril group compared with baseline levels (p<0.001). FMD was positively correlated with insulin sensitivity index (r=0.32, p<0.05) and NOx levels (r=0.39, p=0.01) and negatively correlated with TBARS levels (r=-0.53, p=0.0002) in hypertensive patients. Conclusion Inhibition of the renin-angiotensin system, either with ACE inhibitors or AT(1)-receptor blockers improves endothelial dysfunction. ACE inhibition has prominent effects on improving insulin sensitivity and decreasing oxidative stress in essential hypertensive patients.